Comparison of Three Maintenance Protocols for First-line Intravesical Gemcitabine in Asian Patients with Non-muscle-invasive Bladder Cancer: A Multicenter, Retrospective Cohort Study
Publication date: Available online 6 November 2026 Source: Clinical Genitourinary Cancer Author(s): Jong Kil Nam, Hyeok Jun Goh, Cheol Kyu Oh, Ki Soo Lee, Tae Nam Kim
Comparison of Three Maintenance Protocols for First-line Intravesical Gemcitabine in Asian Patients with Non-muscle-invasive Bladder Cancer: A Multicenter, Retrospective Cohort Study. // Clinical Genitourinary Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S1558767326002119?dgcid=rss_sd_all
Comparison of Three Maintenance Protocols for First-line Intravesical Gemcitabine in Asian Patients with Non-muscle-invasive Bladder Cancer: A Multicenter, Retrospective Cohort Study. Clinical Genitourinary Cancer. https://www.sciencedirect.com/science/article/pii/S1558767326002119?dgcid=rss_sd_all
“Comparison of Three Maintenance Protocols for First-line Intravesical Gemcitabine in Asian Patients with Non-muscle-invasive Bladder Cancer: A Multicenter, Retrospective Cohort Study.” Clinical Genitourinary Cancer.
@article{article41178,
title = {Comparison of Three Maintenance Protocols for First-line Intravesical Gemcitabine in Asian Patients with Non-muscle-invasive Bladder Cancer: A Multicenter, Retrospective Cohort Study},
journal = {Clinical Genitourinary Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S1558767326002119?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...